Elucidating the role of Myosin 5b in intestinal inflammation

阐明肌球蛋白 5b 在肠道炎症中的作用

基本信息

  • 批准号:
    10883872
  • 负责人:
  • 金额:
    $ 22.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-06-06 至 2025-01-31
  • 项目状态:
    未结题

项目摘要

The intestinal epithelium plays an essential role in homeostasis and health by maintaining a barrier and responding appropriately to luminal antigens and bacterial signals. The epithelium accomplishes these functions via thousands of actin-rich protrusions known as microvilli. Microvilli harbor proteins which relay information to the epithelial cell. One important protein at the tips of the microvilli is intestinal alkaline phosphatase -an enzyme that detoxify pro-inflammatory bacterial and host derived compounds and minimizes epithelial insults. Microvilli are maintained at the proper height, distance and density by linker proteins known as the intermicrovillar adhesion complex (IMAC). Our preliminary data indicates that IMAC compounds and intestinal alkaline phosphatase are delivered to the apical member of epithelial cells by the molecular motor Myosin 5b. Loss of functional Myosin 5b and subsequent mislocalization of IMACs and intestinal alkaline phosphatase alters the structure and function of microvilli in our animal model, and we postulate that this sets the stage for epithelial dysfunction. Recently it has been demonstrated that patients with Inflammatory Bowel Disease (IBD) have decreased gene expression of Myosin 5b and have shortened, disordered microvilli on their epithelial cells. Our preliminary data indicates that Myosin 5b protein is decreased in colonic biopsies of IBD patients and in a TNBS mouse model of colitis. We hypothesize that inflammation decreases Myosin 5b gene expression and protein levels, which leads to the mislocalization of IMAC and intestinal alkaline phosphatase protein and perpetuates a cycle of inflammation. To address this question, we propose to define the role of Myosin 5b in intestinal inflammation using acute (DSS) and chronic (T-cell transfer) animal colitis models (Aim 1) and define the mechanisms by which pro-inflammatory stimuli downregulate Myosin 5b and how decreased Myosin 5b sets the stage for further insults using mouse and human intestinal organoids (Aim 2). This work has the potential to identify key pathways involved in intestinal inflammation; targets which could be used to develop next generation therapeutics. This research may lead to treatments which enhance patient health outcomes and quality of life.
肠上皮通过维持屏障并对腔内抗原和细菌信号作出适当反应,在体内平衡和健康中发挥重要作用。上皮通过被称为微绒毛的数千个富含肌动蛋白的突起来完成这些功能。微绒毛含有向上皮细胞传递信息的蛋白质。微绒毛顶端的一种重要蛋白质是肠碱性磷酸酶,这种酶可以解毒促炎细菌和宿主衍生的化合物,并将上皮损伤降到最低。微绒毛通过称为微绒毛间粘附复合物(IMAC)的连接蛋白保持在适当的高度、距离和密度。我们的初步数据表明,IMAC化合物和肠碱性磷酸酶通过分子马达肌球蛋白5b传递到上皮细胞的顶端成员。在我们的动物模型中,功能性肌球蛋白5b的缺失以及随后imac和肠道碱性磷酸酶的错误定位改变了微绒毛的结构和功能,我们假设这为上皮功能障碍奠定了基础。最近有研究表明,炎症性肠病(IBD)患者Myosin 5b基因表达降低,上皮细胞上的微绒毛缩短、紊乱。我们的初步数据表明,在IBD患者的结肠活检和TNBS结肠炎小鼠模型中,Myosin 5b蛋白减少。我们假设炎症降低Myosin 5b基因表达和蛋白水平,从而导致IMAC和肠道碱性磷酸酶蛋白的错误定位,并使炎症循环持续下去。为了解决这个问题,我们建议使用急性(DSS)和慢性(t细胞转移)动物结肠炎模型(Aim 1)来确定Myosin 5b在肠道炎症中的作用,并确定促炎刺激下调Myosin 5b的机制,以及Myosin 5b的降低如何为小鼠和人类肠道类器官的进一步损伤奠定基础(Aim 2)。这项工作有可能确定参与肠道炎症的关键途径;可以用来开发下一代疗法的靶点。这项研究可能会导致改善患者健康结果和生活质量的治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Amy C Engevik其他文献

Amy C Engevik的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Amy C Engevik', 18)}}的其他基金

The role of Myosin Vb in hepatocyte protein trafficking
肌球蛋白 Vb 在肝细胞蛋白质运输中的作用
  • 批准号:
    9806158
  • 财政年份:
    2019
  • 资助金额:
    $ 22.43万
  • 项目类别:
The role of Myosin Vb in Hepatocyte Protein Trafficking
肌球蛋白 Vb 在肝细胞蛋白质运输中的作用
  • 批准号:
    10401609
  • 财政年份:
    2019
  • 资助金额:
    $ 22.43万
  • 项目类别:
The role of Myosin Vb in Hepatocyte Protein Trafficking
肌球蛋白 Vb 在肝细胞蛋白质运输中的作用
  • 批准号:
    10581503
  • 财政年份:
    2019
  • 资助金额:
    $ 22.43万
  • 项目类别:
The role of Myosin Vb in Hepatocyte Protein Trafficking
肌球蛋白 Vb 在肝细胞蛋白质运输中的作用
  • 批准号:
    10360533
  • 财政年份:
    2019
  • 资助金额:
    $ 22.43万
  • 项目类别:
Deficits in Enterocyte Apical Transporters Associated with Loss of Myosin Vb
与肌球蛋白 Vb 丢失相关的肠细胞顶端转运蛋白缺陷
  • 批准号:
    9403155
  • 财政年份:
    2017
  • 资助金额:
    $ 22.43万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 22.43万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了